Home  |  Contact

Cellosaurus HEC-88nu (CVCL_2932)

Cell line name HEC-88nu
Synonyms HEC-88 nu; HEC88nu; HEC88NU; HEC-88
Accession CVCL_2932
Resource Identification Initiative To cite this cell line use: HEC-88nu (RRID:CVCL_2932)
Comments Part of: MD Anderson Cell Lines Project.
Population: Japanese.
Characteristics: Established from a tumor transplanted in nude mice.
Doubling time: 43.8 hours (Note=At 58th passage) (DOI=10.5795/jjscc.26.433); 48 hours (PubMed=2064198).
Omics: Protein expression by reverse-phase protein arrays.
Disease Endometrial adenocarcinoma (NCIt: C7359)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
STR profile Source(s): JCRB; PubMed=25877200

Markers:
AmelogeninX
CSF1PO9,11
D2S133819,23
D3S135815,17
D5S81811,12
D7S82011
D8S117913,16
D13S3178,13
D16S53911
D18S5114,16,17
D19S43313
D21S1129,31.2
FGA21,22
Penta D9,12
Penta E5,15
TH016,7
TPOX8,11
vWA18,19

Run an STR similarity search on this cell line
Web pages https://tcpaportal.org/mclp/
Publications

DOI=10.5795/jjscc.26.433
Morisawa T.
The results of primary culture of endometrial adenocarcinoma and characterization of its established cell line.
Nihon Rinsho Saibo Gakkai Zasshi 26:433-442(1987)

PubMed=2064198; DOI=10.1111/j.1749-6632.1991.tb37884.x
Kuramoto H., Nishida M., Morisawa T., Hamano M., Hata H., Kato Y., Ohno E., Iida T.
Establishment and characterization of human endometrial cancer cell lines.
Ann. N. Y. Acad. Sci. 622:402-421(1991)

PubMed=12227503; DOI=10.1111/j.1749-0774.2002.tb00103.x
Kuramoto H., Hamano M., Imai M.
HEC-1 cells.
Hum. Cell 15:81-95(2002)

DOI=10.1007/978-4-431-53981-0_1
Kuramoto H., Hamano M., Imai M., Fujisawa T., Kamata Y., Arai T., Kawaguchi M.
HEC-1 cells: establishment of an in vitro experimental system in endometrial carcinoma.
(In) Cell and molecular biology of endometrial carcinoma; Kuramoto H., Nishida M. (eds.); pp.3-34; Springer; Tokyo (2003)

PubMed=15053063
Kamata Y., Watanabe J., Hata H., Hamano M., Kuramoto H.
Quantitative study on the correlation between p53 gene mutation and its expression in endometrial carcinoma cell lines.
Eur. J. Gynaecol. Oncol. 25:55-60(2004)

PubMed=25877200; DOI=10.1038/nature14397
Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections (Providers) JCRB; JCRB1121
JCRB; NIHS0393 - Discontinued
Biological sample resources BioSample; SAMN03470941
Encyclopedic resources Wikidata; Q54882269
Polymorphism and mutation databases Cosmic; 1223493
Cosmic; 1696751
IARC_TP53; 21069
Entry history
Entry creation04-Apr-2012
Last entry update05-Oct-2023
Version number20